Aarey Drugs & Pharmaceuticals Ltd is engaged in manufacturing and trading of APIs and Bulk Drugs and offers a range of products for diverse industrial applications.
Financial Results:
- Aarey Drugs & Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹50.96 Crores down from ₹118.84 Crore year on year, a fall of 57.12%.
- Total Expenses for Q1FY24 of ₹50.93 Crores down from ₹118.89 Crores year on year, a fall of 57.16%.
- Consolidated Net Profit of ₹0.72 Crores down 10.0% from ₹0.80 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹0.28, down 12.50% from ₹0.32 in the same quarter of the previous year.